-
Every sheriff needs a deputy: Targeting non-parenchymal cells to treat hepatic fibrosis J. Hepatol. (IF 25.7) Pub Date : 2024-04-26 Brett M. McGettigan, Vijay H. Shah
-
Recurrent splanchnic and extrasplanchnic thrombotic events in patients with non-cirrhotic portal vein thrombosis associated with local factors J. Hepatol. (IF 25.7) Pub Date : 2024-04-26 Isabelle Ollivier-Hourmand MD, Louise Lebedel MD, Berta Bartroli Alabau MD, Odile Goria MD, Christophe Bureau MD PhD, Jérome Dumortier MD PhD, Alexandra Heurgué MD, Christine Silvain MD PhD, Victor De-Ledinghen MD PhD, Pierre-Emmanuel Rautou MD PhD, Audrey Payancé MD, Teresa García Ballester MD PhD, Edilmar Alvarado-Tapias MD PhD, Virginia Hernández-Gea MD PhD, Dominique Valla MD PhD, Kamal Zekrini
-
Reply to: “Democratising the scientific method” J. Hepatol. (IF 25.7) Pub Date : 2024-04-22 Paolo Angeli
-
Comparison of non-contrast abbreviated magnetic resonance imaging and ultrasonography as surveillance modalities for HCC: A multicenter prospective trial J. Hepatol. (IF 25.7) Pub Date : 2024-04-16 Dong Hwan Kim, Jeong Hee Yoon, Moon Hyung Choi, Chang Hee Lee, Tae Wook Kang, Hyun A. Kim, Young-Mi Ku, Jeong Min Lee, Seong Hyun Kim, Kyung Ah Kim, Su Lim Lee, Joon-Il Choi
-
The pathophysiology of polycystic liver disease J. Hepatol. (IF 25.7) Pub Date : 2024-04-09 Renée Duijzer, Melissa M. Boerrigter, Tom J.G. Gevers, Joost P.H. Drenth
-
JNJ-73763989 and bersacapavir treatment in nucleos(t)ide analogue-suppressed patients with chronic hepatitis B: REEF-2 J. Hepatol. (IF 25.7) Pub Date : 2024-04-05 Kosh Agarwal, Maria Buti, Florian van Bömmel, Pietro Lampertico, Ewa Janczewska, Marc Bourliere, Thomas Vanwolleghem, Oliver Lenz, Thierry Verbinnen, Thomas N. Kakuda, Cristiana Mayer, John Jezorwski, Daniel Muenz, Maria Beumont, Ronald Kalmeijer, Michael Biermer, Isabelle Lonjon-Domanec
-
Polyploidisation pleiotropically buffers ageing in hepatocytes J. Hepatol. (IF 25.7) Pub Date : 2024-04-05 Kelvin Yin, Maren Büttner, Ioannis K. Deligiannis, Mateusz Strzelecki, Liwei Zhang, Carlos Talavera-López, Fabian Theis, Duncan T. Odom, Celia P. Martinez-Jimenez
-
Genetic risk accentuates dietary effects on hepatic steatosis, inflammation and fibrosis in a population-based cohort J. Hepatol. (IF 25.7) Pub Date : 2024-04-04 Vincent L. Chen, Xiaomeng Du, Antonino Oliveri, Yanhua Chen, Annapurna Kuppa, Brian D. Halligan, Michael A. Province, Elizabeth K. Speliotes
-
Reply to: “Increase in HDV replication during steroid therapy – potential implications for testing and treatment strategies” J. Hepatol. (IF 25.7) Pub Date : 2024-04-04 Gabriele Ricco, Maurizia R. Brunetto
-
Multicentre phase II trial of cabozantinib in patients with hepatocellular carcinoma after immune checkpoint inhibitor treatment J. Hepatol. (IF 25.7) Pub Date : 2024-04-01 Stephen L. Chan, Baek-Yeol Ryoo, Frankie Mo, Landon L. Chan, Jaekyung Cheon, Leung Li, Kwan H. Wong, Nicole Yim, Hyeyeong Kim, Changhoon Yoo
-
Erratum to ‘JAK1 promotes HDV replication and is a potential target for antiviral therapy’ [J Hepatol 80 (2024) 220-231] J. Hepatol. (IF 25.7) Pub Date : 2024-03-30 Margaux J. Heuschkel, Charlotte Bach, Laura Meiss-Heydmann, Emma Gerges, Emanuele Felli, Fabio Giannone, Patrick Pessaux, Catherine Schuster, Julie Lucifora, Thomas F. Baumert, Eloi R. Verrier
-
Acute-on-chronic liver failure – steps towards harmonization of the definition! J. Hepatol. (IF 25.7) Pub Date : 2024-03-28 Anand V. Kulkarni, Shiv Kumar Sarin
Acute-on-chronic liver failure (ACLF), usually precipitated by alcohol misuse or viral reactivation, is characterised by rapid onset and usually reversible liver failure. Various definitions of ACLF have been proposed and widely used across the globe, including those by APASL, COSSH, EASL-CLIF, Japanese experts, and NACSELD. Although all the definitions have several similarities and connote high short-term
-
Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases J. Hepatol. (IF 25.7) Pub Date : 2024-03-28 Maja Thiele, Ida Falk Villesen, Lili Niu, Stine Johansen, Karolina Sulek, Suguru Nishijima, Lore Van Espen, Marisa Keller, Mads Israelsen, Tommi Suvitaival, Andressa de Zawadzki, Helene Bæk Juel, Maximilian Joseph Brol, Sara Elizabeth Stinson, Yun Huang, Maria Camilla Alvarez Silva, Michael Kuhn, Ema Anastasiadou, Diana Julie Leeming, Morten Karsdal, Jelle Matthijnssens, Manimozhiyan Arumugam, Louise
The rising prevalence of liver diseases related to obesity and excessive use of alcohol is fuelling an increasing demand for accurate biomarkers aimed at community screening, diagnosis of steatohepatitis and significant fibrosis, monitoring, prognostication and prediction of treatment efficacy. Breakthroughs in omics methodologies and the power of bioinformatics have created an excellent opportunity
-
Reply to: Comments on “An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis” J. Hepatol. (IF 25.7) Pub Date : 2024-03-28 Romée J.A.L.M. Snijders, Anna E.C. Stoelinga, Bart van Hoek, Joost P.H. Drenth
-
Reply to: “Distinction of autoimmune hepatitis from drug-induced autoimmune like hepatitis: The answer lies at the interface” J. Hepatol. (IF 25.7) Pub Date : 2024-03-28 Einar S. Björnsson, M Isabel Lucena, Raul J. Andrade
-
Prospective head-to-head comparison of non-invasive scores for diagnosis of fibrotic MASH in patients with type 2 diabetes J. Hepatol. (IF 25.7) Pub Date : 2024-03-27 Laurent Castera, Philippe Garteiser, Cédric Laouenan, Tiphaine Vidal-Trécan, Anaïs Vallet-Pichard, Pauline Manchon, Valérie Paradis, Sébastien Czernichow, Dominique Roulot, Etienne Larger, Stanislas Pol, Pierre Bedossa, Jean-Michel Correas, Dominique Valla, Jean-François Gautier, Bernard E. Van Beers, for the QUID NASH investigators, Djamila Bellili, Ouarda Bessadi, Charlene Da Silveira, Fatima Zohra
-
ALT to qHBsAg ratio predicts long-term HBsAg seroclearance after entecavir cessation in Chinese patients with chronic hepatitis B J. Hepatol. (IF 25.7) Pub Date : 2024-03-26 Ryan Hin-Man Leung, Rex Wan-Hin Hui, Lung-Yi Mak, Xianhua Mao, Kevin Sze-Hang Liu, Danny Ka-Ho Wong, James Fung, Wai-Kay Seto, Man-Fung Yuen
-
Planar cell polarity is crucial for proper morphogenesis of the bile ducts J. Hepatol. (IF 25.7) Pub Date : 2024-03-26 Frédéric P. Lemaigre
-
Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting J. Hepatol. (IF 25.7) Pub Date : 2024-03-26 Mitra K. Nadim, John A. Kellum, Lui Forni, Claire Francoz, Sumeet K. Asrani, Marlies Ostermann, Andrew S. Allegretti, Javier A. Neyra, Jody C. Olson, Salvatore Piano, Lisa B. VanWagner, Elizabeth C. Verna, Ayse Akcan-Arikan, Paolo Angeli, Justin M. Belcher, Scott W. Biggins, Akash Deep, Guadalupe Garcia-Tsao, Yuri S. Genyk, Pere Gines, Patrick S. Kamath, Sandra L. Kane-Gill, Manish Kaushik, Nuttha
Patients with cirrhosis are prone to developing acute kidney injury (AKI), a complication associated with a markedly increased in-hospital morbidity and mortality, along with a risk of progression to chronic kidney disease. Whereas patients with cirrhosis are at increased risk of developing any phenotype of AKI, hepatorenal syndrome (HRS), a specific form of AKI (HRS-AKI) in patients with advanced
-
Treatment response and clinical event-free survival in autoimmune hepatitis: A Canadian multicentre cohort study J. Hepatol. (IF 25.7) Pub Date : 2024-03-24 Christina G. Plagiannakos, Gideon M. Hirschfield, Ellina Lytvyak, Surain B. Roberts, Marwa Ismail, Aliya F. Gulamhusein, Nazia Selzner, Karim M. Qumosani, Lawrence Worobetz, Julian Hercun, Catherine Vincent, Jennifer A. Flemming, Mark G. Swain, Angela Cheung, Tianyan Chen, Dusanka Grbic, Kevork Peltekain, Andrew L. Mason, Aldo J. Montano-Loza, Bettina E. Hansen, the Canadian Network for Autoimmune
-
Developing and validating clinical prediction models in hepatology – An overview for clinicians J. Hepatol. (IF 25.7) Pub Date : 2024-03-24 Rickard Strandberg, Peter Jepsen, Hannes Hagström
Prediction models are everywhere in clinical medicine. We use them to assign a diagnosis or a prognosis, and there have been continuous efforts to develop better prediction models. It is important to understand the fundamentals of prediction modelling, thus, we herein describe nine steps to develop and validate a clinical prediction model with the intention of implementing it in clinical practice:
-
Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure J. Hepatol. (IF 25.7) Pub Date : 2024-03-21 Georg Semmler, Sonia Alonso López, Monica Pons, Sabela Lens, Elton Dajti, Marie Griemsmann, Alberto Zanetto, Lukas Burghart, Stefanie Hametner-Schreil, Lukas Hartl, Marisa Manzano, Sergio Rodriguez-Tajes, Paola Zanaga, Michael Schwarz, María Luisa Gutierrez, Mathias Jachs, Anna Pocurull, Benjamín Polo, Dominik Ecker, Beatriz Mateos, Sonia Izquierdo, Yolanda Real, Adriana Ahumada, David Josef Maria
-
Transplant benefit-based offering of deceased donor livers in the United Kingdom J. Hepatol. (IF 25.7) Pub Date : 2024-03-21 Elisa Allen, Rhiannon Taylor, Alexander Gimson, Douglas Thorburn, the Core Group of the NHS Blood and Transplant Liver Advisory Group
-
Evaluation of a delayed liver transplantation strategy for patients with HCC receiving bridging therapy: the DELTA-HCC study J. Hepatol. (IF 25.7) Pub Date : 2024-03-21 Catherine Lamarque, Lauriane Segaux, Philippe Bachellier, Benjamin Buchard, Faiza Chermak, Filomena Conti, Thomas Decaens, Sébastien Dharancy, Vincent Di Martino, Jérôme Dumortier, Claire Francoz-Caudron, Jean Gugenheim, Jean Hardwigsen, Fabrice Muscari, Sylvie Radenne, Ephrem Salamé, Thomas Uguen, José Ursic-Bedoya, Corinne Antoine, Aurélie Deshayes, Christian Jacquelinet, Pierre-André Natella, Vincent
-
Unraveling the liver antiviral immunity in functional cure of chronic hepatitis B using scRNAseq J. Hepatol. (IF 25.7) Pub Date : 2024-03-19 Pierre Tonnerre, Thomas F. Baumert
-
FASN-mediated fatty acid biosynthesis remodels immune environment in Clonorchis sinensis infection-related intrahepatic cholangiocarcinoma J. Hepatol. (IF 25.7) Pub Date : 2024-03-19 Lixia Xu, Ying Zhang, Zhilong Lin, Xinlang Deng, Xiaoxue Ren, Mingle Huang, Shangru Li, Qianying Zhou, Fei Fang, Qingxia Yang, Gaomin Zheng, Zebin Chen, Zhongdao Wu, Xi Sun, Jie Lin, Jingxian Shen, Jianping Guo, Xiaoxing Li, Tianchen Xue, Jing Tan, Xiaoxuan Lin, Li Tan, Hong Peng, Shunli Shen, Sui Peng, Shaoqiang Li, Lijian Liang, James M. Cleary, Jiaming Lai, Yubin Xie, Ming Kuang
-
Phenotypes and ontogeny of senescent hepatic stellate cells in metabolic dysfunction-associated steatotic liver disease J. Hepatol. (IF 25.7) Pub Date : 2024-03-18 Chittampalli N. Yashaswini, Tianyue Qin, Dipankar Bhattacharya, Corina Amor, Scott Lowe, Amaia Lujambio, Shuang Wang, Scott L. Friedman
-
Targeting IL-1 in severe alcohol-related hepatitis: How many frogs will we need to kiss to find an effective therapy? J. Hepatol. (IF 25.7) Pub Date : 2024-03-16 Mark Thursz, Philippe Mathurin
-
Reply to: “irLI or not irLI: That is the question” J. Hepatol. (IF 25.7) Pub Date : 2024-03-13 Ciro Celsa, Giuseppe Cabibbo, David James Pinato
-
Expanding the Dialogue: A Closer Look at AIH Management and HCC Risk J. Hepatol. (IF 25.7) Pub Date : 2024-03-13 Dan Shan PhD
-
The MAFLD and MASLD conundrum: Is it reinvention of the wheel? J. Hepatol. (IF 25.7) Pub Date : 2024-03-13 Mariana M. Ramírez-Mejía, Mohammed Eslam, Nahum Méndez-Sánchez
-
Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis J. Hepatol. (IF 25.7) Pub Date : 2024-03-11 Ann Thu Ma, Cristina Solé, Adrià Juanola, Laia Escudé, Laura Napoleone, Emma Avitabile, Martina Pérez-Guasch, Marta Carol, Enrico Pompili, Jordi Gratacós-Ginés, Anna Soria, Ana Belén Rubio, Marta Cervera, Maria José Moreta, Manuel Morales-Ruiz, Elsa Solà, Esteban Poch, Núria Fabrellas, Isabel Graupera, Elisa Pose, Pere Ginès
-
Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta J. Hepatol. (IF 25.7) Pub Date : 2024-03-11 Mathias Jachs, Lisa Sandmann, Lukas Hartl, Tammo Tergast, Michael Schwarz, David Josef Maria Bauer, Lorenz Balcar, Alena Ehrenbauer, Benedikt Silvester Hofer, Markus Cornberg, Henrike Lenzen, Katja Deterding, Michael Trauner, Mattias Mandorfer, Heiner Wedemeyer, Thomas Reiberger, Benjamin Maasoumy
-
One-year transplant-free survival following hospital discharge after ICU admission for ACLF in the Netherlands J. Hepatol. (IF 25.7) Pub Date : 2024-03-11 Jubi de Haan, Fabian Termorshuizen, Nicolette de Keizer, Diederik Gommers, Caroline den Hoed
-
Efficacy of stereotactic ablative radiotherapy in patients with oligometastatic hepatocellular carcinoma: A phase II study J. Hepatol. (IF 25.7) Pub Date : 2024-03-11 Seo Hee Choi, Byung min Lee, Jina Kim, Do Young Kim, Jinsil Seong
-
Democratising the scientific method J. Hepatol. (IF 25.7) Pub Date : 2024-03-08 Shivaram Prasad Singh, Prajna Anirvan
-
Reply to: “Ultrasensitive HBsAg testing predicts HBsAg seroreversion outcomes: Considerations for new and existing therapies” J. Hepatol. (IF 25.7) Pub Date : 2024-03-08 Marc G. Ghany, Maria Buti, Pietro Lampertico, Hannah M. Lee
-
Pkd1l1-deficiency drives biliary atresia through ciliary dysfunction in biliary epithelial cells J. Hepatol. (IF 25.7) Pub Date : 2024-03-08 Yi Zou Lim, Min Zhu, Yunguan Wang, Tripti Sharma, Shannon Kelley, Estelle Oertling, Hao Zhu, Natasha Corbitt
-
Endothelial POFUT1 controls injury-induced liver fibrosis by repressing fibrinogen synthesis J. Hepatol. (IF 25.7) Pub Date : 2024-03-07 Shan He, Yuru Luo, Wangge Ma, Xiaoke Wang, Chengrong Yan, Wenyang Hao, Yuan Fang, Hongyu Su, Baochang Lai, Junhui Liu, Ying Xiong, Ting Bai, Xiaoyong Ren, Enqi Liu, Hua Han, Yue Wu, Zuyi Yuan, Yidong Wang
-
Van Gogh-like 2 is essential for the architectural patterning of the mammalian biliary tree J. Hepatol. (IF 25.7) Pub Date : 2024-03-07 Michaela Raab, Ersi Christodoulou, Roopesh Krishnankutty, Andreea Gradinaru, Alexander Daniel Walker, Paula Olaizola, Nicholas Thomas Younger, Anabel Martinez Lyons, Edward Joseph Jarman, Konstantinos Gournopanos, Alexander von Kriegsheim, Scott Hamilton Waddell, Luke Boulter
-
Cutting edges in the HBV genome: How RNA splicing is involved in modulating virus ultrastructure to promote infection J. Hepatol. (IF 25.7) Pub Date : 2024-03-07 Stefan Seitz, Ralf Bartenschlager
-
Syngeneic murine models with distinct immune microenvironments represent subsets of human intrahepatic cholangiocarcinoma J. Hepatol. (IF 25.7) Pub Date : 2024-03-07 Jennifer L. Tomlinson, Binbin Li, Jingchun Yang, Emilien Loeuillard, Hannah E. Stumpf, Hendrien Kuipers, Ryan Watkins, Danielle M. Carlson, Jessica Willhite, Daniel R. O’Brien, Rondell P. Graham, Xin Chen, Rory L. Smoot, Haidong Dong, Gregory J. Gores, Sumera I. Ilyas
-
The Synergism of Public Health Policies and Social Work May Reduce Mortality from Cancer, Liver Disease and Cardiovascular Disease J. Hepatol. (IF 25.7) Pub Date : 2024-03-06 Shijie GUO, Jingqiang ZENG
-
Reply to: “Familial clustering of MASLD: Rethinking strategies for population screening” J. Hepatol. (IF 25.7) Pub Date : 2024-03-06 Fahim Ebrahimi, Jonas F. Ludvigsson
-
Uric acid in pediatric MASLD definition: Is it time to implement diagnostic criteria? J. Hepatol. (IF 25.7) Pub Date : 2024-03-06 Anna Di Sessa, Stefano Guarino, Giuseppina Rosaria Umano, Emanuele Miraglia del Giudice, Pierluigi Marzuillo
-
Rare monogenic causes of steatotic liver disease masquerading as MASLD J. Hepatol. (IF 25.7) Pub Date : 2024-03-06 Martijn C.G.J. Brouwers, David Cassiman
-
Autoimmune hepatitis: Mycophenolate mofetil vs. azathioprine as first-line therapy J. Hepatol. (IF 25.7) Pub Date : 2024-03-06 Cem Şimşek, Staffan Wahlin, Cumali Efe
-
Multi-omics characterization of healthy and PSC human liver – what we knew and what we have learned J. Hepatol. (IF 25.7) Pub Date : 2024-02-28 Jenny Krause, Christoph Schramm
-
Using liver stiffness to predict and monitor the risk of decompensation and mortality in patients with alcohol-related liver disease J. Hepatol. (IF 25.7) Pub Date : 2024-02-28 Katrine Holtz Thorhauge, Georg Semmler, Stine Johansen, Katrine Prier Lindvig, Maria Kjærgaard, Johanne Kragh Hansen, Nikolaj Torp, Camilla Dalby Hansen, Peter Andersen, Benedikt Silvester Hofer, Wenyi Gu, Mads Israelsen, Mattias Mandorfer, Thomas Reiberger, Jonel Trebicka, Maja Thiele, Aleksander Krag, the Microb-Predict Galaxy and MicrobLiver consortia
-
Multidrug-resistant bacterial infections after liver transplantation: Prevalence, impact, and risk factors J. Hepatol. (IF 25.7) Pub Date : 2024-02-28 Rosa Martin-Mateos, Laura Martínez-Arenas, Ángela Carvalho-Gomes, Laia Aceituno, Valle Cadahía, Magdalena Salcedo, Ana Arias, Sara Lorente, Aitor Odriozola, Javier Zamora, Marino Blanes, Óscar Len, Laura Benítez, Isabel Campos-Varela, María Luisa González-Diéguez, Diego Rojo Lázaro, Jesús Fortún, Antonio Cuadrado, Natalia Marcos Carrasco, Manuel Rodríguez-Perálvarez, Carmen Álvarez-Navascues, Emilio
-
Single-cell landscape of functionally cured chronic hepatitis B patients reveals activation of innate and altered CD4-CTL-driven adaptive immunity J. Hepatol. (IF 25.7) Pub Date : 2024-02-28 Balakrishnan Chakrapani Narmada, Atefeh Khakpoor, Niranjan Shirgaonkar, Sriram Narayanan, Pauline Poh Kim Aw, Malay Singh, Kok Haur Ong, Collins Oduor Owino, Jane Wei Ting Ng, Hui Chuing Yew, Nu Soibah Binte Mohamed Nasir, Veonice Bijin Au, Reina Sng, Nivashini Kaliaperumal, Htet Htet Toe Wai Khine, Francesca Casuscelli di Tocco, Otsuka Masayuki, Shamita Naikar, Hui Xin Ng, Su Li Chia, Cindy Xin Yi
-
PTEN deficiency induces an extrahepatic cholangitis-cholangiocarcinoma continuum via aurora kinase A in mice J. Hepatol. (IF 25.7) Pub Date : 2024-02-28 Yan Yang, Jiale Wang, Jianhua Wan, Qianqian Cheng, Zenong Cheng, Xueli Zhou, Oliver Wang, Kelvin Shi, Lingxiang Wang, Bin Wang, Xiaohui Zhu, Jiaxiang Chen, Dongfeng Feng, Yang Liu, Yasmin Jahan-mihan, Ashley N. Haddock, Brandy H. Edenfield, Guang Peng, Jessica D. Hohenstein, Chantal E. McCabe, Daniel R. O'Brien, Chen Wang, Sumera I. Ilyas, Liuyan Jiang, Michael S. Torbenson, Huamin Wang, Raouf E. Nakhleh
-
Comment on “Population-based screening works: Effect of integrating screening for hepatitis B and C into the general health check-up in Germany” J. Hepatol. (IF 25.7) Pub Date : 2024-02-23 Renke Biallas, Ruth Zimmermann, Sandra Dudareva
-
Potential augmentation of terlipressin antidiuretic effects by gabapentinoids J. Hepatol. (IF 25.7) Pub Date : 2024-02-23 Penelope N. Markham, Jasmohan S. Bajaj, Paul J. Thuluvath, David Koch, Joseph Palumbo
-
Changing from NAFLD to MASLD: The implications for health-related quality of life data J. Hepatol. (IF 25.7) Pub Date : 2024-02-23 Ryuki Hashida, Dan Nakano, Machiko Kawaguchi, Zobair M. Younossi, Takumi Kawaguchi
-
Autoimmune hepatitis: Azathioprine or mycophenolate mofetil for inducing remission? J. Hepatol. (IF 25.7) Pub Date : 2024-02-23 Avinash Tiwari, Duncan Khanikar, Santosh Govind Rathod
-
CRKL dictates anti-PD-1 resistance by mediating tumor-associated neutrophil infiltration in hepatocellular carcinoma J. Hepatol. (IF 25.7) Pub Date : 2024-02-23 Peiyi Xie, Mincheng Yu, Bo Zhang, Qiang Yu, Yufei Zhao, Mengyuan Wu, Lei Jin, Jiuliang Yan, Binghai Zhou, Shuang Liu, Xiaoqiang Li, Chenhao Zhou, Xiaodong Zhu, Cheng Huang, Yongfeng Xu, Yongsheng Xiao, Jian Zhou, Jia Fan, Mien-Chie Hung, Qinghai Ye, Lei Guo, Hui Li
-
An in-depth exploration of difference and similarity between NAFLD and MASLD J. Hepatol. (IF 25.7) Pub Date : 2024-02-23 Yubo Liu, Liao Tan
-
Should MMF treatment be the first-line therapy in autoimmune hepatitis? J. Hepatol. (IF 25.7) Pub Date : 2024-02-23 Laurent Alric
-
Let’s unite Hepatology! Become an EASL member today and discover your benefits J. Hepatol. (IF 25.7) Pub Date : 2024-02-15